Concourse Financial Group Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,104
Closed -$29.9K 132
2024
Q4
$29.9K Buy
1,104
+34
+3% +$837 ﹤0.01% 1406
2024
Q3
$27.4K Hold
1,070
﹤0.01% 1429
2024
Q2
$25.1K Buy
1,070
+43
+4% +$1.08K ﹤0.01% 1446
2024
Q1
$29.5K Sell
1,027
-123
-11% -$3.7K ﹤0.01% 1391
2023
Q4
$37.7K Buy
1,150
+193
+20% +$5.25K ﹤0.01% 1240
2023
Q3
$26.7K Sell
957
-90
-9% -$2.94K ﹤0.01% 1345
2023
Q2
$35.7K Buy
1,047
+16
+2% +$503 ﹤0.01% 1212
2023
Q1
$31K Buy
1,031
+24
+2% +$744 ﹤0.01% 1290
2022
Q4
$28.4K Buy
+1,007
New +$32K ﹤0.01% 1331
2022
Q3
Sell
-1,023
Closed -$37.6K 2059
2022
Q2
$32K Sell
1,023
-419
-29% -$14.7K ﹤0.01% 1258
2022
Q1
$66K Sell
1,442
-19,846
-93% -$946K ﹤0.01% 1029
2021
Q4
$1.3M Buy
21,288
+5,657
+36% +$391K 0.07% 266
2021
Q3
$1.17M Buy
15,631
+7,466
+91% +$626K 0.07% 278
2021
Q2
$755K Buy
8,165
+1,942
+31% +$165K 0.05% 367
2021
Q1
$552K Buy
6,223
+2,398
+63% +$238K 0.04% 408
2020
Q4
$357K Buy
3,825
+3,343
+694% +$266K 0.03% 454
2020
Q3
$31K Buy
+482
New +$28.2K ﹤0.01% 1217

Other funds holding ARKG

Concourse Financial Group Securities's ARKG Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 1,104 shares — an estimated $29.9K sold.

Concourse Financial Group Securities first reported a position in ARKG in Q3 2020 and held it in 17 quarters. The position peaked at $1.3M in Q4 2021. 215 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,104 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $29.9K.
  • Concourse Financial Group Securities first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 17 quarters.
  • Concourse Financial Group Securities's ARK Genomic Revolution ETF position peaked at $1.3M in Q4 2021.
  • 215 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.